CN102895453A - Drug for treating mammitis - Google Patents
Drug for treating mammitis Download PDFInfo
- Publication number
- CN102895453A CN102895453A CN2012104021116A CN201210402111A CN102895453A CN 102895453 A CN102895453 A CN 102895453A CN 2012104021116 A CN2012104021116 A CN 2012104021116A CN 201210402111 A CN201210402111 A CN 201210402111A CN 102895453 A CN102895453 A CN 102895453A
- Authority
- CN
- China
- Prior art keywords
- medicine
- drug
- mastitis
- treatment
- mammitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for treating mammitis. The drug for treating the mammitis is prepared by taking Rehmannia Glutinosa, safflower carthamus, rhizoma cyperi, Ligusticum wallichii and liquorice as raw materials. The drug can be made into clinically used tablets, capsules, pills, particles, powder, injections or paste. The drug has the functions of soothing liver to smoothing Qi and tonifying the spleen and kidney and is very good in curative effect on diseases, such as the mammitis and hyperplasia of mammary glands. The drug for treating the mammitis is safe and reliable in clinical use and has no obvious toxic and side effects.
Description
Technical field
The present invention relates to the medicine for the treatment of mastitis, specially refer to a kind of medicine of the treatment mastitis that prepare take Chinese herbal medicine as raw material, the invention still further relates to the preparation method of this medicine.
Background technology
Mastitis refer to breast epithelium and proliferation of fibrous tissue, mammary gland tissue conduit and newborn lobule degeneration structurally and the growth of carrying out property connective tissue, and its pathogenic factor mainly is because the endocrine hormone imbalance.In recent years, along with the change of people's mode of operation and the quickening of rhythm of life, the mastitis sickness rate is the trend that rises year by year, age also more and more becomes younger, mastitis are the modal cystic hyperplasia of breast of women, its sickness rate accounts for the first place of mastopathy, some mastitis delay treatment even may cause pathological changes.So should enhance your vigilance to mastitis, as early as possible treatment.
The medicine of western medicine mastitis is more at present, because doctor trained in Western medicine is not yet fully clear to this sick mechanism, the most drug treatment is devoted to eliminate surperficial pain symptom, such as such as RUKUAIXIAO, RUPIXIAO, Tabellae Asparagini, PINGXIAO PIAN, the spirit of capsule addiction, tamoxifen etc., also have in addition some hormone medicines, these medicines and life-time service are all very large to the side effect of human body, and easily recurrence usually is difficult to radical cure after the treatment.
Motherland's medical science thinks, this disease is because depressed rage impairing the liver, worry impairing spleen, qi stagnation blood stasis, expectorant congeal into due to the nuclear, and Chinese medicine is referred to as " nodules of the breast ".Existing this sick Chinese medicine for the treatment of is often for a kind of specific symptom, and the reason of mastitis is more, does not therefore often affect therapeutic effect because do not suit the medicine to the illness.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine that is applicable to multiple mastitis, and its therapeutic effect is good, and cost is low, and toxic and side effects is less.
The preparation method that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be made by the raw material of following quality proportioning:
Radix Rehmanniae Preparata 10-18, Flos Carthami 5-15, Rhizoma Cyperi 7-15, Rhizoma Chuanxiong 5-15, Radix Glycyrrhizae 5-10.
The further quality proportioning of each component of medicine of the present invention is:
Radix Rehmanniae Preparata 15, Flos Carthami 10, Rhizoma Cyperi 12, Rhizoma Chuanxiong 10, Radix Glycyrrhizae 7.
The concrete preparation method of medicine of the present invention may further comprise the steps:
The Chinese medicine of above-mentioned mass fraction is mixed, the clear water that adds 200-400 weight portions, 0.5-1.5 hours at a simmer, after repeatedly frying in shallow oil 3 times, take out medicinal residues, marmite is put in 3 medicinal liquid mixing fried in shallow oil 2-4 hours, medicinal liquid is condensed into the thick paste shape, then add conventional adjuvant, make tablet, capsule, pill, granule, powder, injection or the unguentum of clinical use.
The traditional Chinese medical science is thought, the mutual relation that close complexity is arranged between the human five internal organs, interact between liver, gallbladder, spleen, the stomach, counteract each other, mastitis have many reasons, in general, women's sentimentality, the fire of one unsatisfactory then conscience is sprung into life, and the Liver Channel lactogenesis follows row two sides of body, causes stagnation of QI expectorant to coagulate in breast.So the traditional Chinese medical science generally adopts the method treatment of soothing liver-QI for relieving depression, promoting the circulation of QI and reducing phlegm, can also promote that vim and vigour are unimpeded, guarantees therapeutic effect.
In the prescription of the present invention, Radix Rehmanniae Preparata is sweet, and tepor is returned liver, kidney channel, the yin nourishing of enriching blood, life essence-filling, marrow-benefitting; The Rhizoma Cyperi resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving; The Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping; The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription; All medicine reasonable compatibilities in the side, complementary collaborative, dialectical treatment, depressed liver-energy dispersing and QI regulating, warming and recuperating the spleen and kidney has good curative effect for diseases such as multiple mastitis.
Actual efficacy for checking medicine of the present invention, use medicine of the present invention and cooperate clinical treatment mastitis patient 100 examples, the result cures 79 examples, cure rate is 79%, 16 examples that are clearly better, total effective rate 95%, clinical test results proves, curative effect of medication of the present invention is definite, and has no side effect, and clinical practice is safe and reliable.
The specific embodiment
Embodiment 1:
Prepare raw material according to following weight:
Radix Rehmanniae Preparata 11 kg, Flos Carthami 6 kg, Rhizoma Cyperi 14kg, Rhizoma Chuanxiong 6 kg, Radix Glycyrrhizae 9kg.
The Chinese medicine of above-mentioned mass fraction is mixed, add the clear water of 30kg weight portion, 0.5-1.5 hours at a simmer, after repeatedly frying in shallow oil 3 times, take out medicinal residues, marmite is put in 3 medicinal liquid mixing fried in shallow oil 2-4 hours, medicinal liquid is condensed into the thick paste shape, then adds conventional adjuvant, make the tablet of clinical use.
Embodiment 2:
Prepare raw material according to following weight:
Radix Rehmanniae Preparata 15 kg, Flos Carthami 10 kg, Rhizoma Cyperi 12 kg, Rhizoma Chuanxiong 10 kg, Radix Glycyrrhizae 7kg.
The Chinese medicine of above-mentioned mass fraction is mixed, add the clear water of 30kg weight portion, 0.5-1.5 hours at a simmer, after repeatedly frying in shallow oil 3 times, take out medicinal residues, marmite is put in 3 medicinal liquid mixing fried in shallow oil 2-4 hours, medicinal liquid is condensed into the thick paste shape, then adds conventional adjuvant, make the pill of clinical use.
Claims (3)
1. medicine for the treatment of mastitis is characterized in that described medicine is the medicament of being made by the raw material of following quality proportioning:
Radix Rehmanniae Preparata 10-18, Flos Carthami 5-15, Rhizoma Cyperi 7-15, Rhizoma Chuanxiong 5-15, Radix Glycyrrhizae 5-10.
2. the medicine for the treatment of mastitis according to claim 1 is characterized in that described medicine is the medicament of being made by the raw material of following quality proportioning:
Radix Rehmanniae Preparata 15, Flos Carthami 10, Rhizoma Cyperi 12, Rhizoma Chuanxiong 10, Radix Glycyrrhizae 7.
3. the preparation method for the treatment of mastitis medicine according to claim 1 and 2, it is characterized in that the Chinese medicine of getting above-mentioned mass fraction mixes, the clear water that adds 200-400 weight portions, 0.5-1.5 hours at a simmer, repeatedly fry in shallow oil 3 times after, take out medicinal residues, marmite is put in 3 medicinal liquid mixing to be fried in shallow oil 2-4 hours, medicinal liquid is condensed into the thick paste shape, then adds conventional adjuvant, make tablet, capsule, pill, granule, powder, injection or the unguentum of clinical use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104021116A CN102895453A (en) | 2012-10-22 | 2012-10-22 | Drug for treating mammitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104021116A CN102895453A (en) | 2012-10-22 | 2012-10-22 | Drug for treating mammitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102895453A true CN102895453A (en) | 2013-01-30 |
Family
ID=47568139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104021116A Pending CN102895453A (en) | 2012-10-22 | 2012-10-22 | Drug for treating mammitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102895453A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102151325A (en) * | 2011-04-13 | 2011-08-17 | 苑学 | Traditional Chinese medicine for treating breast diseases |
-
2012
- 2012-10-22 CN CN2012104021116A patent/CN102895453A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102151325A (en) * | 2011-04-13 | 2011-08-17 | 苑学 | Traditional Chinese medicine for treating breast diseases |
Non-Patent Citations (1)
| Title |
|---|
| 李小英: "中西医结合治疗急性乳腺炎的方法探讨", 《河 北 医 学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102430092A (en) | Traditional Chinese medicine composition for treating stomach cold and stomachache | |
| CN103463587A (en) | Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach | |
| CN104107395A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN104758825A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN103330805A (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN101485862B (en) | Chinese medicament preparation for treating mastopathy | |
| CN101843694A (en) | Chinese medicament for treating chronic hepatitis | |
| CN102091141A (en) | Medicament for treating gout and preparation method thereof | |
| CN103386089A (en) | Chinese medicine composition for treating liver-stomach disharmony | |
| CN105833003A (en) | Traditional Chinese medicine composition for treating autism | |
| CN101837111A (en) | Medicament for curing proliferation of mammary glands and preparation method thereof | |
| CN105250873A (en) | Traditional Chinese medicine composition for treating pregnancy vomiting | |
| CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
| CN102228624A (en) | Medicament for treating pharyngitis and preparation method thereof | |
| CN100493542C (en) | Traditional Chinese medicine for treating hemopathy | |
| CN102895453A (en) | Drug for treating mammitis | |
| CN102085350A (en) | Medicament for treating arthritis and preparation method thereof | |
| CN104888132A (en) | Traditional Chinese medicine composition for treatment of chronic gastritis | |
| CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
| CN101850046B (en) | Chinese medicament for treating chronic hepatitis | |
| CN1326555C (en) | Chinese medicinal powder preparation for treating hepatic ascites | |
| CN101757138A (en) | Medicament for treating erythra and preparation method thereof | |
| CN106620121A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia caused by stagnation of qi due to depression of the liver | |
| CN104758540A (en) | Traditional Chinese medicine composition for treating postpartum hypogalactia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130130 |